VNDA
Vanda Pharmaceuticals Inc
NASDAQ: VNDA · HEALTHCARE · BIOTECHNOLOGY
$5.05
-2.13% today
Updated 2026-07-29
Market cap
$327.14M
P/E ratio
—
P/S ratio
1.50x
EPS (TTM)
$-4.06
Dividend yield
—
52W range
$4 – $10
Volume
0.9M
Vanda Pharmaceuticals Inc (VNDA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.05
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$36.89
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -2.73% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -110.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.